NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Authors
Keywords
-
Journal
BRAIN
Volume 143, Issue 5, Pages 1414-1430
Publisher
Oxford University Press (OUP)
Online
2020-03-06
DOI
10.1093/brain/awaa084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
- (2019) Takahiro Masuda et al. NATURE
- Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction
- (2017) S. Samuel Weigt et al. JOURNAL OF CLINICAL INVESTIGATION
- An updated histological classification system for multiple sclerosis lesions
- (2016) Tanja Kuhlmann et al. ACTA NEUROPATHOLOGICA
- Human Monocytes Engage an Alternative Inflammasome Pathway
- (2016) Moritz M. Gaidt et al. IMMUNITY
- An interferon-β-resistant and NLRP3 inflammasome–independent subtype of EAE with neuronal damage
- (2016) Makoto Inoue et al. NATURE NEUROSCIENCE
- NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis
- (2015) Sunny Malhotra et al. BRAIN
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Mechanisms of inflammasome activation: recent advances and novel insights
- (2015) Sivapriya K. Vanaja et al. TRENDS IN CELL BIOLOGY
- NLRP3 inflammasome and its inhibitors: a review
- (2015) Bo-Zong Shao et al. Frontiers in Pharmacology
- Unknown
- (2014) Charles Dinarello MOLECULAR MEDICINE
- Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
- (2014) Silvia Rossi et al. Molecular Neurodegeneration
- A critical role for interleukin-1β in the progression of autoimmune diseases
- (2013) Ruijuan Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Oxidative Stress and Proinflammatory Cytokines Contribute to Demyelination and Axonal Damage in a Cerebellar Culture Model of Neuroinflammation
- (2013) Alessandra di Penta et al. PLoS One
- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- The Q705K Polymorphism in NLRP3 Is a Gain-of-Function Alteration Leading to Excessive Interleukin-1β and IL-18 Production
- (2012) Deepti Verma et al. PLoS One
- Activated Human CD4+CD45RO+ Memory T-Cells Indirectly Inhibit NLRP3 Inflammasome Activation through Downregulation of P2X7R Signalling
- (2012) Vanessa Beynon et al. PLoS One
- NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis
- (2012) M. Inoue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interferon- Therapy Against EAE Is Effective Only When Development of the Disease Depends on the NLRP3 Inflammasome
- (2012) M. Inoue et al. Science Signaling
- Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis
- (2011) Silvia Rossi et al. ANNALS OF NEUROLOGY
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis
- (2011) David Baker et al. JOURNAL OF NEUROIMMUNOLOGY
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Cutting Edge: Critical Role for PYCARD/ASC in the Development of Experimental Autoimmune Encephalomyelitis
- (2010) P. J. Shaw et al. JOURNAL OF IMMUNOLOGY
- NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses
- (2010) D. Gris et al. JOURNAL OF IMMUNOLOGY
- The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18
- (2010) S. Jha et al. JOURNAL OF NEUROSCIENCE
- TopHat: discovering splice junctions with RNA-Seq
- (2009) Cole Trapnell et al. BIOINFORMATICS
- A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
- (2009) X. Montalban et al. Multiple Sclerosis Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More